| Not Yet Recruiting | A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet NCT07285967 | Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Phase 1 |
| Recruiting | A Study of GensSci098 in Subjects With Graves' Disease NCT07286656 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) NCT07016802 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Single Ascending Dose and Multiple Ascending Dose Study of AVR-48 NCT06847698 | AyuVis Research, Inc. | Phase 1 |
| Active Not Recruiting | A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults NCT06633562 | Lohocla Research Corporation | Phase 1 |
| Recruiting | Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers. NCT06752122 | RNATICS GmbH | Phase 1 |
| Completed | A Phase 1 Study of Y-3 in US Healthy Volunteers. NCT06770491 | Neurodawn Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Evaluation of Safety and Human Tolerance of Oral Probiotic Streptococcus Salivarius eK12 NCT06380270 | Liaquat University of Medical & Health Sciences | N/A |
| Recruiting | Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors NCT06639256 | Sichuan Huiyu Pharmaceutical Co., Ltd | Phase 1 / Phase 2 |
| Not Yet Recruiting | Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer NCT06539091 | Anhui Provincial Hospital | Phase 3 |
| Recruiting | A Study of GenSci098 in Subjects With Active Thyroid Eye Disease NCT06569758 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation NCT06243354 | Sichuan Huiyu Pharmaceutical Co., Ltd | Phase 1 / Phase 2 |
| Completed | SB17170 Phase1 Trial in Healthy Volunteer NCT05795192 | SPARK Biopharma | Phase 1 |
| Completed | Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers NCT05847218 | RH Nanopharmaceuticals | Phase 1 |
| Completed | Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers NCT05698095 | Usona Institute | Phase 1 |
| Completed | Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study NCT05556291 | Getz Pharma | — |
| Completed | Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midaz NCT05633147 | Cinclus Pharma Holding AB | Phase 1 |
| Completed | Clinical Trial on Pharmacokinetics and Tolerability of AP707 NCT05267769 | CannaXan GmbH | Phase 1 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants NCT05143905 | AstraZeneca | Phase 1 |
| Recruiting | Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors NCT05142592 | Nanjing Immunophage Biotech Co., Ltd | Phase 1 / Phase 2 |
| Completed | Study Evaluating the Safety and Tolerability of a Probioitc NCT05044949 | BioGaia AB | N/A |
| Completed | Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects NCT04691115 | AnaMar AB | Phase 1 |
| Completed | Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+ NCT04693429 | Laboratorios Sophia S.A de C.V. | Phase 1 |
| Completed | Clinical Trial on Pharmacokinetic and Tolerability of AP701 NCT04708795 | CannaXan GmbH | Phase 1 |
| Completed | Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South NCT05697887 | Number 2 Children's Hospital, Ho Chi Minh City | N/A |
| Completed | Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers NCT06879067 | Tiziana Life Sciences LTD | Phase 1 |
| Terminated | TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms NCT03503968 | Medigene AG | Phase 1 / Phase 2 |
| Completed | A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD NCT02512575 | AstraZeneca | Phase 1 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Hea NCT02484729 | AstraZeneca | Phase 1 |
| Terminated | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese P NCT02209506 | Takeda | Phase 1 |
| Completed | Assessment of Novel Respiratory Protective Devices in Healthcare NCT02082158 | National Center for Occupational Health and Infection Control | N/A |
| Completed | Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Part NCT02107885 | Daiichi Sankyo | Phase 1 |
| Completed | To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy NCT01818869 | AstraZeneca | Phase 1 |
| Completed | Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects NCT02054754 | e-Therapeutics PLC | Phase 1 |
| Completed | A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans NCT01981928 | Astellas Pharma Europe B.V. | Phase 1 |
| Completed | A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal NCT01959685 | Repros Therapeutics Inc. | Phase 1 |
| Completed | Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches NCT01841801 | Chattem, Inc. | N/A |
| Completed | Evaluation of Experimental Heat Patch NCT01841788 | Chattem, Inc. | N/A |
| Unknown | Music During Diagnostic Hysteroscopy NCT01703871 | Campus Bio-Medico University | — |
| Completed | Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects NCT02206204 | Actelion | Phase 1 |
| Completed | Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of NCT01954589 | Idorsia Pharmaceuticals Ltd. | Phase 1 |
| Completed | Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers NCT01348737 | AstraZeneca | Phase 1 |
| Completed | Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study NCT01158755 | Universitas Padjadjaran | Phase 2 |
| Completed | Single Centre, Double-blind, Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects NCT01166698 | AstraZeneca | Phase 1 |
| Completed | Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjec NCT01154621 | AstraZeneca | Phase 1 |
| Completed | Study to Investigate Single Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects NCT01121302 | AstraZeneca | Phase 1 |
| Withdrawn | Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 NCT01086813 | AstraZeneca | Phase 1 |
| Unknown | Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating NCT00967317 | Laboratorios Osorio de Moraes Ltda. | Phase 3 |
| Completed | Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients NCT01023282 | NeuroSearch A/S | Phase 1 |
| Unknown | Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety NCT00944268 | Ativus Farmaceutica Ltda | Phase 3 |
| Completed | Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor NCT01260025 | Sun Yat-sen University | Phase 1 |